Dyne Therapeutics, Inc 10-Q for FY2026 Q2
Dyne Therapeutics, Inc. (DYN)
10-Q
2026-07-29
For: 2026-06-30
View Original
Added on
July 29, 2026
About this 10-Q
Dyne Therapeutics, Inc filed this 10-Q on July 29, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $178.56M
- compared with a net loss of $110.86M a year earlier
- Diluted EPS
- -$1.08
- compared with -$0.97 a year earlier